Inactive Instrument
Quotes Regulus Therapeutics Inc.
Stocks
RGLS
US75915K3095
Biotechnology & Medical Research
Stock exchange
Nasdaq
RGLS 8.160 $
+0.25%
76.23M
$
| Markets | Price | Change | Volumes |
|---|
Performance
| 1 day | +0.25% | ||
| 3 years | +500.00% | ||
| 5 years | +17.07% | ||
| 10 years | -98.04% |
Volumes
marketsCapital turnover ratio
0.04
Float rotation
0.05
Basic data
Market Cap (USD)
616,987,489
Number of employees
34
Sales / Employee ()
0
Sales / Employee (USD)
0
Free-Float
90.92%
Free-Float capitalization (USD)
525,454,525
Average Daily Capital Traded
4.13%
Indicators
Moving average 5 days
8.12
Moving average 20 days
8.08
Moving average 50 days
6.65
Moving average 100 days
4.02
Price spread / (MMA5)
-0.49%
Price spread / (MMA20)
-0.98%
Price spread / (MMA50)
-18.50%
Price spread / (MMA100)
-50.74%
RSI 9 days
57.99
RSI 14 days
66.62
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.25% | -.--% | -.--% | +500.00% | 617M | |
| -4.10% | -8.35% | +38.48% | +66.99% | 66.22B | |
| -0.41% | +4.99% | +7.61% | +72.82% | 55.2B | |
| +0.74% | +7.31% | +12.50% | +88.71% | 52.79B | |
| +0.61% | +6.22% | +27.28% | +50.97% | 45.53B | |
| -1.08% | +8.76% | +21.07% | +131.38% | 43.94B | |
| -3.39% | -3.01% | +250.89% | +571.04% | 41.64B | |
| -1.67% | +8.06% | +14.17% | +56.67% | 34B | |
| -8.38% | -9.01% | +25.65% | -1.82% | 25.84B | |
| +1.30% | +6.97% | +38.37% | +28.59% | 23.51B | |
| Average | -1.61% | +3.43% | +43.60% | +156.53% | 38.93B | |
| Weighted average by Cap. | -1.69% | +3.43% | +46.98% | +122.97% |
Historical Quotes: Regulus Therapeutics Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Price Extremes
| 3 years | 0.83 |  | 8.34 |
| 5 years | 0.76 | | 8.34 |
| 10 years | 0.76 | | 405 |
Monthly variations
Annual variations
| 2025 | +416.46% | ||
| 2024 | +23.44% | ||
| 2023 | -6.57% | ||
| 2022 | -56.51% | ||
| 2021 | -76.67% | ||
| 2020 | +51.69% | ||
| 2019 | -4.36% | ||
| 2018 | -92.54% | ||
| 2017 | -53.78% | ||
| 2016 | -74.20% | ||
| 2015 | -45.64% | ||
| 2014 | +117.05% | ||
| 2013 | +17.30% | ||
| 2012 | +50.00% |
